An early block in B-cell development and a gene dose-sensitive MZ B-cell deficiency. (A) Frequencies of major B-cell subsets in bone marrow, peritoneum, and spleen. (B) Expression of the IL-7R α chain in early (B220loCD43+) and late (B220loCD43−) B-cell progenitors. (C) Forward scatter (FSC) profiles of the subsets in B indicate relative sizes of wild-type and Fnip1 mutant cells. (D) Reduced frequency of IgMhi cells in Fnip1+/ham heterozygotes (n = 3). (E) Reduced frequency of splenic MZ B cells (CD21/35hiCD23lo or CD21/35hiIgMhi) and MZ precursors (MZP) (CD21/35hiIgMhiCD23hi). (F) Absolute numbers of transitional (T1, CD93+CD23−; T2, CD93+CD23+IgMint; T3, CD93+CD23+IgMhi;), follicular (CD21/35intCD23hi), MZP, or MZ B cells in spleen. (G) Serum levels of NP-specific IgM antibodies before (preimmune) and after immunization with NP-Ficoll. Plots in A and E are representative of three mice per genotype. Symbols in B, F, and G represent individual mice, with bars representing the means (± SEM). P values calculated by unpaired two-tailed t test.